UCAR T-cell therapy targeting CD19/BCMA

· Zhejiang University

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for UCAR T-cell therapy targeting CD19/BCMA, covering 2025-04-09 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [NA]